News and media

Protect yourself and your older community from common viruses like COVID-19 and flu. These are respiratory infections can make you cough and sneeze, give you a runny nose sore throat or fever. COVID-19 and flu can also get worse and lead to headaches, aches, shortness of breath and chest pain.

COVID-19 vaccination rates are lower than needed to protect our older community, particularly aged care residents.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of XBB 1.5 COVID-19 vaccines.

An update from Australia's Chief Medical Officer, Professor Paul Kelly, on the end of the COVID-19 emergency response.

On 20 October 2023, Australia’s Chief Medical Officer declared that COVID-19 is no longer a Communicable Disease Incident of National Significance (CDINS) following the end of winter in Australia. The Australian Health Protection Principal Committee (AHPPC) supports this declaration.

The Australian Technical Advisory Group on Immunisation (ATAGI) recently updated their advice for the COVID-19 booster dose.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding an additional COVID-19 dose for highest risk people in 2023. These recommendations are in addition to the previous ATAGI COVID-19 vaccine booster advice published in February 2023.

The Coronavirus (COVID-19) Common Operating Picture (COP) has been discontinued.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

See details on the pre-departure testing requirement for COVID-19 for people travelling to Australia from China, including Hong Kong and Macau.

The Minister for Health has determined the end of the COVIDSafe data period effective from 16 August 2022. All COVIDSafe app data has now been deleted from the National COVIDSafe Data Store. 

The Australian Government will introduce pre-departure testing for COVID-19 for people travelling to Australia from the People’s Republic of China.

The Australian Government is committed to supporting effective COVID-19 testing to limit the spread and ensure that those most at risk of severe disease have fast access to care and treatments.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years (Pfizer 6 months to 4 years).

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November 2022.

A new children’s song has been created to help remind families how to avoid viral infections like COVID-19.